Summary
Acute experimental allergic encephalomyelitis (EAE) was induced in Hartley guinea pigs and Lewis rats, which were then treated with synthetic serum thymic factor (FTS). When a dose of 30 μg/100 g body weight of FTS was subcutaneously administered to the animals on days — 1 (before inoculation), 4, 9 and 15 intermittently, clinical symptoms of acute EAE were suppressed. Histopathological evaluation showed that the severity of EAE in FTS-treated guinea pigs was less than in unteated guinea pigs. Immunohistochemical examination showed that the numbers of OX6+, W3/25+, W3/13+ and OX19+ cells in FTS-treated rats were less than in untreated rats and that the number of OX8+ cells in FTS-treated rats was greater than in untreated rats. These findings suggest that FTS induced OX8+ cells in inflammatory lesions and suppressed inflammation in acute EAE.
Similar content being viewed by others
References
Bach JF (1983) Thymulin (FTS-Zn). Clin Immunol Allergy 3:133–156
Bach JF, Dardenne M, Pleau JM, Bach MA (1975) Isolation, biochemical characteristics, and biological activity of a circulating thymic hormone in the mouse and in the human. Ann NY Acad Sci 249:186–210
Bach JF, Dardenne M, Pleau JM, Rosa J (1977) Biochemical characterisation of a serum thymic factor. Nature 266:55–57
Bach JF, Bach MA, Blanot D, Bricas E, Charreire J, Dardenne M, Fournier C, Pleau JM (1978) Thymic serum factor (FTS). Bull Inst Pasteur 76:325–398
Bach MA, Niaudet P (1976) Thymic function in NZB mice. II. Regulatory influence of a circulating thymic factor on antibody production against polyvinylpyrrolidone in NZB mice. J Immunol 117:760–764
Bach MA, Fournier C, Bach JF (1975) Regulation ofϑ-antigen expression by agents altering cyclic AMP level and by thymic factor. Ann NY Acad Sci 249:316–327
Barclay AN (1981) The localization of populations of lymphocytes defined by monoclonal antibodies in rat lymphoid tissues. Immunology 42:593–600
Ben-Nun A, Cohen IR (1982) Experimental autoimmune encephalomyelitis (EAE) mediated by T cell lines: process of selection of lines and characterization of the cells. J Immunol 129:303–308
Bliznakov EG, Wan YP, Chang D, Folkers K (1978) Partial reactivation of impaired immune competence in aged mice by synthetic thymus factors. Biochem Biophys Res Commun 80:631–636
Hickey WF, Gonatas NK (1984) Suppressor T-lymphocytes in the spinal cord of Lewis rats recovered from acute experimental allergic encephalomyelitis. Cell Immunol 85:284–288
Hickey WF, Gonatas NK, Kimura H, Wilson DB (1983) Identification and quantitation of T lymphocyte subsets found in the spinal cord of the Lewis rat during acute experimental allergic encephalomyelitis. J Immunol 131:2805–2809
Lacombe M, Perner F, Dardenne M, Bach JF (1974)Thymectomy in the young pig: effects on the level of circulating thymic hormone. Surgery 76:556–559
Lassmann H (1983) Comparative neuropathology of chronic experimental allergic encephalomyelitis and multiple sclerosis. Springer, Berlin Heidelberg New York Tokyo, pp 1–94
Lassmann H, Vass K, Brunner Ch, Seitelberger F (1986) Characterization of inflammatory infiltrates in experimental allergic encephalomyelitis. Progr Neuropathol 6:33–62
Moore GRW, Traugott U, Stone SH, Raine CS (1985) Dose dependency of MBP-induced demyelination in the guinea pig. J Neurol Sci 70:197–205
Moore GRW, McCarron RM, Traugott U, McFarlin DE, Raine CS (1987) Critical threshold for dose of myelin basic protein in murine autoimmune encephalomyelitis. J Neurol Sci 77:173–184
Nagai Y, Osanai T, Sakakibara K (1982) Intensive suppression of experimental allergic encephalomyelitis (EAE) by serum thymic factor and therapeutic implication for multiple sclerosis. Jpn J Exp Med 52:213–219
Pettinelli CB, McFarlin DE (1981) Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+2−T lymphocytes. J Immunol 127:1420–1423
Raine CS (1985) Experimental allergic encephalomyelitis and experimental allergic neuritis. Handb Clin Neurol 47:429–466
Rovenský J, Grimová J, Pekárek J, Korčáková L (1981) The effects of thymosin (fraction V) on adjuvant diseases in rats. Thymus 3:51–53
Schulof RS, Goldstein AL (1981) Thymosins and other thymic hormones. In: Hadden J, Stewart M (eds) The lymphokines Humana Press, Clifton, pp 397–423
Trotter J, Sriram S, Rassenti L, Chou CHJ, Fritz RB, Steinman L (1985) Characterization of T cell lines and clones from SJL/J and (BALB/cxSJL/J)F1 mice specific for myelin basic protein. J Immunol 134:2322–2327
Wiśniewski HM, Keith AB (1977) Chronic relapsing experimental allergic encephalomyelitis: an experimental model of multiple sclerosis. Ann Neurol 1:144–148
Woyciechowska J, Goldstein AL, Driscoll B (1985) Experimental allergic encephalomyelitis in guinea pigs: influence of thymosin fraction V on the disease. J Neuroimmunol 7:215–219
Author information
Authors and Affiliations
Additional information
Supported partly by a grant (1987) from the Neuroimmunological Disorders Research Committee, the Ministry of Health and Welfare of Japan
Rights and permissions
About this article
Cite this article
Kato, S., Nakamura, H. Suppression of acute experimental allergic encephalomyelitis by synthetic serum thymic factor. Acta Neuropathol 75, 337–344 (1988). https://doi.org/10.1007/BF00687786
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00687786